表紙
市場調查報告書

SNP基因型鑑定的全球市場 - 成長,趨勢,預測(2019年∼2024年)

SNP Genotyping Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 851123
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
價格
Back to Top
SNP基因型鑑定的全球市場 - 成長,趨勢,預測(2019年∼2024年) SNP Genotyping Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年02月01日內容資訊: 英文 112 Pages
簡介

全球SNP基因型鑑定市場在2018年估算為123億美金。今後預計將以21%的年複合成長率擴大,2024年達到386億美元。

本報告提供全球SNP基因型鑑定市場調查,市場概要,各類型,各地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買方議價能力
    • 供應商談判力
    • 替代產品及服務的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各技術
    • TaqMan SNP基因型鑑定
    • Massarray SNP基因型鑑定
    • SNP GeneChip陣列
    • 其他
  • 各終端用戶
    • 藥理基因學
    • 診斷領域
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東&非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Agilent Technologies Inc.
    • Beckman Coulter Inc.
    • Bio-Rad Laboratories Inc.
    • Douglas Scientific LLC
    • Illumina Inc.
    • Life Technologies Corp.
    • Luminex Corp.
    • Promega Corporation
    • Thermo Fischer Scientific Inc.

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 66030

Market Overview

The global SNP genotyping market was valued at USD 12.3 billion in 2018, and is estimated to be valued at USD 38.6 billion in 2024, witnessing a CAGR of 21%. The analysis of SNPs is widely utilized in different disciplines of genetics and related studies, commonly associated with studying genetic determinants of many complex diseases. SNP technologies are extensively utilized for detection and are beneficial in the etiology of several human diseases, such as cancer, cardiovascular, Alzheimer's, and asthma, among others.

In addition, SNPs are essential markers in various human ailments and are intensely employed in pharmacogenomics to customize personalized medicine in a better way. Therefore, rising applications of SNPs in several life sciences and biotechnology aspects are driving the SNP genotyping market.

Scope of the Report

Single-nucleotide polymorphism (SNP) refers to mutations found at a specific locus or single base pair mutation containing two alleles. SNPs aid in understanding the correlations between the genotype and behavior indicated by all living organisms. It involves the measurement of variations that commonly occur in individuals. Unlike conventional time-consuming, expensive, and labor-extensive detection technologies, SNP technology is highly efficient, relatively inexpensive, and automated.

Key Market Trends

Pharmogenics Led the End-user Segment of the SNP Genotyping Market in 2018

Under end users, pharmacogenomics is the leading segment. The large share of pharmacogenomics is primarily due to the increasing pipeline for personalized medicine and novel drug delivery systems, which are extensively exploiting SNP in genetic materials for drug development applications.

North America had Largest Share in 2018 in the Global SNP Market, while Asia-Pacific is the Fastest-growing Region

North America is the dominating region in the SNP genotyping market, due to rising commercial research in personalized medicines and animal breeding, among others.

In addition, Asia-Pacific is the fastest-growing market, due to the rising demand for SNP genotyping in emerging economies like China and India, across different fields, which is largely propelling the market's growth.

Competitive Landscape

The SNP genotyping market is highly competitive and consists of several major players. In terms of market share, a small number of major players currently dominate the market. Key strategies adopted by major players in this market include product launches, collaborations, and agreements.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Miniaturization of Equipment and Instruments
    • 4.2.2 Increased Multiplexing Capacity Leading to Increased Application
  • 4.3 Market Restraints
    • 4.3.1 Lack of Standardisation in SNP Processes
    • 4.3.2 Privacy Concerns Pose a Threat to Broad Technology Adoption
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Technology
    • 5.1.1 TaqMan SNP Genotyping
    • 5.1.2 Massarray SNP Genotyping
    • 5.1.3 SNP GeneChip Arrays
    • 5.1.4 Other Technologies
  • 5.2 End User
    • 5.2.1 Pharmacogenomics
    • 5.2.2 Diagnostic Field
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies Inc.
    • 6.1.2 Beckman Coulter Inc.
    • 6.1.3 Bio-Rad Laboratories Inc.
    • 6.1.4 Douglas Scientific LLC
    • 6.1.5 Illumina Inc.
    • 6.1.6 Life Technologies Corp.
    • 6.1.7 Luminex Corp.
    • 6.1.8 Promega Corporation
    • 6.1.9 Thermo Fischer Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top